Actively Recruiting
Maternal-fetal Outcomes of Genital Blood Loss Beyond 18 Weeks of Pregnancy
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-01-31
300
Participants Needed
1
Research Sites
163 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The primary objective is to assess in terms of frequency the adverse outcomes (premature birth, maternal-fetal haemorrhage, maternal fetal-neonatal death) of pregnancies of women attending the obstetric-gynaecological emergency department for genital bleeding beyond the 18th week of pregnancy.
CONDITIONS
Official Title
Maternal-fetal Outcomes of Genital Blood Loss Beyond 18 Weeks of Pregnancy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnancy beyond 18 weeks gestational age complicated by genital bleeding
- Age of the patient �3E�3D 18 years
- Delivery at the O.U. of Obstetrics and Prenatal Age Medicine
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Bologna, Italy, 40138
Actively Recruiting
Research Team
E
Elisa Montaguti, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here